Squamous Cell Lung Cancer
1 competing product in clinical development for Squamous Cell Lung Cancer.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Necitumumab-Gemcitabine-Cisplatin | Eli Lilly | Phase 2 | Terminated | 52 |
1 competing product in clinical development for Squamous Cell Lung Cancer.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| Necitumumab-Gemcitabine-Cisplatin | Eli Lilly | Phase 2 | Terminated | 52 |